Abstract
In a previous study we found an expansion of circulating memory (CD45RO+) CD4+ T cells in patients with Crohn's disease (CD). The aim of this work was to investigate the phenotypic and functional characteristics of this T-cell subset in CD. We analyzed in peripheral blood CD4+CD45RO+ T cells from CD patients the expression of surface markers associated to immune activation, costimulation, and apoptosis. In sorted CD4+CD45RO+ T cells apoptosis was quantified by fluorescent annexin V binding. Healthy subjects and patients with ulcerative colitis and acute bacterial enterocolitis served as control groups. An increased percentage of memory CD4+CD45RO+ T cells lacking the expression of costimulatory receptor CD28 was detected in patients with active CD when compared to the other groups evaluated. This expanded CD4+CD45RO+CD28null T-cell subset expressed mostly the effector-cell marker CD57+. Both CD28 downregulation and CD57 expression correlated to CDAI and surrogate markers of disease activity. These phenotypic changes observed on CD4+CD45RO+ T cells from active CD returned to values similar to healthy controls after clinical remission. Moreover, this memory CD28νll T-cell subset might express more intracytoplasmic TNF and IFN-γ than their CD28+ counterpart. Significantly lower frequencies of memory CD4+CD45RO+ T cells expressing CD95 apoptosis receptor were found in patients with active CD. Moreover, sorted CD4+CD45RO+and CD4+CD45RO+ CD28null T cells from patients with active CD exhibited a lower apoptotic rate than that found in healthy controls and inactive CD patients. According to our data, circulating T lymphocytes from active CD patients show distinctive phenotypic and functional changes, characterized by an expansion of memory CD4+CD45RO+CD28null T cells expressing effector-associated cell surface molecules and displaying enhanced resistance to apoptosis.
Similar content being viewed by others
REFERENCES
Fiocchi C: Inflammatory bowel disease: Etiology and pathogenesis. Gastroenterology 115:182-205, 1998
Elson CO: The immunology of inflammatory bowel disease. In Inflammatory Bowel Disease, JB Kirsner (ed). New York, Raven Press, 2000, pp 208-239
Podolsky DK: Inflammatory bowel disease. N Engl J Med 347:417-429, 2002
Sanahan F: Crohn's disease. Lancet 359:62-69, 2002
Dutton RW, Bradley LM, Swain L: T cell memory. Annu Rev Immunol 16:201-223, 1998
Sprent J, Surh CD: Generation and maintenance of memory T cells. Curr Opin Immunol 13:248-254, 2001
Sprent J, Surh CD: T cell memory. Annu Rev Immunol 20:551-579, 2002
Roman LI, Manzano L, De La Hera A, Abreu L, Rossi I, 2 Expanded CD4+CD45RO+ phenotype and defective proliferative response in T lymphocytes from patients with Crohn's disease. Gastroenterology 110:1008-1019, 1996
Meenan J, Spaans J, Grools TA, Pals ST, Tytgat GN, van Deventer SJ: Altered expression of α4β7, a gut homing integrin, by circulating and mucosal T cells in colonic mucosal inflammation. Gut 40:241-246, 1997
Mariani P, Bachetoni A, D'Alessandro M, Lomanto D, Mazzocchi P, Speranza V: Effector Th-1 cells with cytotoxic function in the intestinal lamina propria of patients with Crohn's disease. Dig Dis Sci 45:2029-2035, 2000
Chakir J, Laviolette M, Turcotte H, Boutet M, Boutet LP: Cytokine expression in the lower airways of nonasthmatics subjects with allergic rhinitis: Influence of natural allergen exposure. J Allergy Clin Immunol 106:904-910, 2000
Wu XM, Osoegawa M, Yamasaki K, Kawano Y, Ochi H, Horiuchi I, Minohara M, Ohyagi Y, Yamada T, Kira JI: Flow cytometric differentiation of Asian and Western types of multiple sclerosis, HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and hyperIgEaemic myelitis by analyses of memory CD4 positive T cell subsets and NK cell subsets. J Neurol Sci 177:24-31, 2000
Crucian B, Dunne P, Friedman H, Ragsdale R, Pross S, Widen R: Alterations in levels of CD28-/CD8+ suppressor cell precursor and CD45RO+/CD4+ memory T lymphocytes in the peripheral blood of multiple sclerosis patients. Clin Diagn Lab Immunol 2:249-252, 1995
Mahmoud F, Abul H, al Saleh Q, Hssab el Naby H, Kajeji M, Haines D, Burleson J, Morgan G: Elevated B-lymphocyte levels in lesional tissue of non-arthritic psoriasis. J Dermatol 26:428-433, 1999
Granstein RD: New treatments for psoriasis. N Engl J Med 345:284-287, 2001
Kweon MN, Takahashi I, Yamamoto H, Jang MH, Suenobu N, Kiyono H: Development of antigen induced colitis in SCID mice reconstituted with spleen derived memory type CD4+ CD45RB+ T cells. Gut 50:299-306, 2002
Lennard-Jones JE: Classification of inflammatory bowel disease. Scand J Gastroenterol 24(Suppl 170):2-6, 1989
Best WR, Becktel JM, Singleton JW, Kern F: Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology; 70:439-444, 1976
Truelove SC, Witts LJ: Cortisone in ulcerative colitis: Final report on a therapeutic trial. BMJ 2:1041-1048, 1955
Garcia-Suarez J, Prieto A, Reyes E, Manzano L, Merino JL, Alvarez-Mon M: Severe chronic autoimmune thrombocytopenic purpura is associated with an expansion of CD56+ CD3- natural killer cells subset. Blood 82:1538-1545, 1993
Prieto A, Reyes E, Garcia-Suarez J, Carrion F, Hernandez MP, Chafer J, Alvarez-Mon M: A low blood lymphocyte count is associated with an expansion of activated cytotoxic T lymphocytes in patients with B cell chronic lymphocytic leukemia. Eur J Haematol 59:89-99, 1997
Prieto A, Reyes E, Diaz D, Hernandez-Fuentes MP, Monserrat J, Perucha E, Muñoz L, Vangioni R, de La Hera A, Orfao A, Alvarez-Mon M: A new method for the simultaneous analysis of growth and death of immunophenotypically defined cells in culture. Cytometry 39:56-66, 2000
Prieto A, Diaz D, Barcenilla H, Garcia-Suarez J, Reyes E, Monserrat J, San Antonio E, Melero D, de la Hera A, Orfao A, Alvarez-Mon M: Apoptotic rate: A new indicator for the quantification of the incidence of apoptosis in cell cultures. Cytometry 48:185-193, 2002
Hamann D, Baars PA, Rep MH, Hooibrink B, Kerkhof-Garde SR, Klein MR, van Lier RA: Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med 186:1407-1418, 1997
Lenschow DJ, Walunas TL, Bluestone JA: CD28/B7 system of T cell costimulation. Annu Rev Immunol 14:233-258, 1996
June CH, Bluestone JA, Nadler LM, Thompson CB. The B7 and CD28 receptor families: Immunol Today 15:321-331, 1994
Seder RA, Germain RN, Linsley PS, Paul WE: CD28-mediated costimulation of interleukin 2 (IL-2) production plays a critical role in T cell priming for IL-4 and interferon gamma production. J Exp Med 179:299-304, 1994
Rulifson IC, Sperling AI, Fields PE, Fitch FW, Bluestone JA: CD28 co-stimulation promotes the production of Th2 cytokines. J Immunol 158:658-665, 1997
Warnier G, Duffour MT, Uyttenhove C, Gajewski TF, Lurquin C, Haddada H, Perricaudet M, Boon T: Induction of a cytolytic T-cell response in mice with a recombinant adenovirus coding for tumor antigen P815A. Int J Cancer 67:303-310, 1996
Martens P, Goronzy JJ, Schaid D, Weyand CM: Expansion of unusual CD4+ T cells in severe rheumatoid arthritis. Arthritis Rheum 40:1106-1114, 1997
Markovic-Plese S, Cortese I, Wandinger KP, McFarland HF, Martin R: CD4+CD28- costimulation-independent T cells in multiple sclerosis. J Clin Invest 108:1185-1194, 2001
Moosig F, Csernok E, Wang G, Gross WL: Costimulatory molecules in Wegener's granulomatosis (WG): Lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells. Clin Exp Immunol 114:113-118, 1998
Liuzzo G, Kopecky SL, Frye RL, O'Fallon WM, Maseri A, Goronzy JJ, Weyand CM: Perturbation of the T-cell repertoire in patients with unstable angina. Circulation 100:2135-2139, 1999.
Vallejo AN, Nestel AR, Schirmer M, Weyand CM, Goronzy JJ: Aging-related deficiency of CD28 expression in CD4+ T cells is associated with the loss of gene-specific nuclear factor binding activity J Biol Chem 273:8119-8129, 1998
Schmidt D, Goronzy JJ, Weyand CM: CD4+CD7-CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest 97:2027-2037, 1996
Park W, Weyand CM, Schmidt D, Goronzy JJ: Co-stimulatory pathways controlling activation and peripheral tolerance of human CD4+CD28- T cells. Eur J Immunol 27:1082-1090, 1997
Duftner C, Goldberger C, Falkenbach A, Würzner R, Falkensammer B, Pfeiffer KP, Maerker-Hermann E, Schirmer M: Prevalence, clinical relevance and characterization of circulating cytotoxic CD4+CD28- T cells in ankylosing spondylitis. Arthritis Res Ther 5:292-300, 2003
Komocsi A, Lamprecht P, Csernok E, Mueller A, Holl-Ulrich K, Seitzer U, Moosig F, Schnabel A, Gross WL: Peripheral blood and granuloma CD4(+)CD28(-) T cells are a major source of interferon-gamma and tumor necrosis factor-alpha in Wegener's granulomatosis. Am J Pathol 160:1717-1724, 2002
Namekawa T, Wagner UG, Goronzy JJ, Weyand CM: Functional subsets of CD4 T cells in rheumatoid synovitis. Arthritis Rheum 41:2108-2116, 1998
Nakajima T, Goek O, Zhang X, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM: De novo expression of killer immunoglobulin-like receptors and signaling proteins regulates the cytotoxic function of CD4 T cells in acute coronary syndromes. Circ Res 93:106-113, 2003
Dubey C, Croft M, Swain L: Naive and effector CD4 T cells differ in their requirements for T cell receptor versus costimulatory signals. J Immunol 157:3280-3289, 1996
Hogan LH, Markofski W, Bock A, Barger B, Morrisey JD, Sandor M: Mycobacterium bovis BCG-induced granuloma formation depends on gamma interferon and CD40 ligand but does not require CD28. Infect Immun 69:2596-2603, 2001
Kern F, Ode-Hakim S, Vogt K, Hoflich C, Reinke P, Volk HD: The enigma of CD57+CD28- T cell expansion. Clin Exp Immunol 104:180-184, 1996
Imberti L, Sottini A, Signorini S, Gorla R, Primi D: Oligoclonal CD4+ CD57+ T-cell expansions contribute to the imbalanced T-cell receptor repertoire of rheumatoid arthritis patients. Blood 89:2822-2232, 1997
Maeda T, Yamada H, Nagamine R, Shuto T, Nakashima Y, Hirata G, Iwamoto Y: Involvement of CD4+, CD57+ T cells in the disease activity of rheumatoid arthritis. Arthritis Rheum 46:379-384, 2002
Iwatani Y, Hidaka Y, Matsuzka F, Kuma K, Amino N: Intrathyroidal lymphocyte subsets, including unusual CD4+ CD8+ cells and CD3loTCR alpha beta lo/-CD4-CD8- cells, in autoimmune thyroid disease. Clin Exp Immunol 93:430-436, 1993
Giscombe R, Nityanand S, Lewin N, Grunewald J, Lefvert AK: Expanded T cell populations in patients with Wegener's granulomatosis: Characteristics and correlates with disease activity. J Clin Immunol 18:404-413, 1998
Mackay CR: Migration pathways and immunologic memory among T lymphocytes. Semin Immunol 4:51-58, 1992
Autschbach F, Schurmann G, Qiao L, Merz H, Wallich R, Meuer SC: Cytokine messenger RNA expression and proliferation status of intestinal mononuclear cells in noninflamed gut and Crohn's disease. Virchows Arch 426:51-60, 1995.
Ghosh S, Goldin E, Gordon FH, Malchow HA, Rask-Madsen J, Rutgeerts P, Vyhnalek P, Zaradova Z, Palmer T, Donoghue S: Natalizumab for active Crohn's disease. N Engl J Med 348:24-32, 2003
Ellis CN, Krueger GG: Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes. N Engl J Med 345:248-255, 2001
Kraan MC, van Kuijk AW, Dinant HJ, Goedkoop AY, Smeets TJ, de Rie MA, Dijkmans BA, Vaishnaw AK, Bos JD, Tak PP. Alefacept treatment in psoriatic arthritis: Reduction of the effector T cell population in peripheral blood and synovial tissue is associated with improvement of clinical signs of arthritis. Arthritis Rheum 46:2776-2784, 2002
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
De Tena, J.G., Manzano, L., Leal, J.C. et al. Active Crohn's Disease Patients Show a Distinctive Expansion of Circulating Memory CD4+CD45RO+CD28null T Cells. J Clin Immunol 24, 185–196 (2004). https://doi.org/10.1023/B:JOCI.0000019784.20191.7f
Issue Date:
DOI: https://doi.org/10.1023/B:JOCI.0000019784.20191.7f